MyAverix Finance
TO · Healthcare
HLS Therapeutics Inc (HLS)
Drug Manufacturers - Specialty & Generic
HLS Therapeutics Inc (HLS) is listed on TO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HLS
HLS Therapeutics Inc (HLS) — FAQ
What is HLS's P/E ratio?
The price-to-earnings (P/E) ratio for HLS Therapeutics Inc (HLS) is 18.00 (data as of 2026-05-24).
Does HLS Therapeutics Inc pay a dividend?
Dividend yield is not available in the current snapshot for HLS Therapeutics Inc (HLS). Check the MyAverix Finance app for the latest dividend data.
What sector is HLS Therapeutics Inc in?
HLS Therapeutics Inc (HLS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is HLS listed on?
HLS is listed on TO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.